Rubric Capital Management (New York)’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,231,483
| Closed | -$9.24M | – | 97 |
|
|
2022
Q2 | $9.24M | Buy |
+1,231,483
| New | +$9.24M | 0.49% | 45 |
|
|
2021
Q2 | – | Sell |
-480,402
| Closed | -$8.59M | – | 77 |
|
|
2021
Q1 | $8.59M | Buy |
+480,402
| New | +$8.59M | 0.5% | 49 |
|
|
2019
Q2 | – | Sell |
-164,070
| Closed | -$7.79M | – | 73 |
|
|
2019
Q1 | $7.79M | Sell |
164,070
-398,115
| -71% | -$18.9M | 0.73% | 42 |
|
|
2018
Q4 | $20.3M | Buy |
+562,185
| New | +$20.3M | 2.51% | 18 |
|